Master's Thesis
iPSC-derived mammary epithelial cells as a model to study the onset of malignant transformation triggered by BRCA mutations
— 2021
Key information
Authors:
Supervisors:
Published in
November 12, 2021
Abstract
Approximately 10-15% of breast cancer cases are associated with hereditary syndromes and most of them have associated mutations in BRCA1 or BRCA2. Indeed, it has been established that the breast cancer risk is 65% and 45% at 70 years of age in women who have BRCA1 gene and BRCA2 gene mutations, respectively, higher than in women with no inherited gene variants. It was demonstrated that mutations in BRCA1 and BRCA2 genes can induce genetic lesions before cancer development. However, these studies were performed using adult mammary tissue, which does not allow to determine the origin of these alterations. Therefore, the main goal of this research project was to derive mammary progenitors from iPSCs to study the molecular mechanisms underlying the malignant transformation of breast cells in women harbouring mutations in BRCA1 or BRCA2 genes. Reprogrammed iPSCs were characterized to guarantee their pluripotency capacity. Further, these cells were used to optimize mammary differentiation protocol. It was demonstrated that the combination of MammoCult medium with BMP4, SU, and SB was able to induce a correct non-neural ectoderm commitment and further mammary differentiation. iPSCs derived from healthy donors and BRCA1 and BRCA2 mutation carriers were, then, differentiated until day 35 to promote a more organized structure in mammary cell aggregates and determine the impact of these mutations in mammary differentiation. Gene expression, immunohistochemistry, and flow cytometry analysis allowed to evaluate the impact of BRCA mutations in mammary differentiation. Preliminary results showed distinct proportions of mammary epithelial subsets in mammary aggregates presenting BRCA mutations.
Publication details
Authors in the community:
Eunice De Melo Gomes Gonçalves
ist186704
Supervisors of this institution:
Tiago Paulo Gonçalves Fernandes
ist147740
Fields of Science and Technology (FOS)
industrial-biotechnology - Industrial Biotechnology
Publication language (ISO code)
eng - English
Rights type:
Embargo lifted
Date available:
September 7, 2022
Institution name
Instituto Superior Técnico